Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 3
2010 10
2011 7
2012 6
2013 3
2014 1
2015 2
2016 5
2017 3
2019 2
2020 1
2021 1
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial.
Siefker-Radtke AO, Matsubara N, Park SH, Huddart RA, Burgess EF, Özgüroğlu M, Valderrama BP, Laguerre B, Basso U, Triantos S, Akapame S, Kean Y, Deprince K, Mukhopadhyay S, Loriot Y; THOR cohort 2 investigators. Siefker-Radtke AO, et al. Ann Oncol. 2024 Jan;35(1):107-117. doi: 10.1016/j.annonc.2023.10.003. Epub 2023 Oct 21. Ann Oncol. 2024. PMID: 37871702 Clinical Trial.
Netrin-1 in cancer: Potential biomarker and therapeutic target?
Kefeli U, Ucuncu Kefeli A, Cabuk D, Isik U, Sonkaya A, Acikgoz O, Ozden E, Uygun K. Kefeli U, et al. Tumour Biol. 2017 Apr;39(4):1010428317698388. doi: 10.1177/1010428317698388. Tumour Biol. 2017. PMID: 28443497 Free article. Review.
Prognostic Factors for Operated Gallbladder Cancer.
Oven Ustaalioglu BB, Bilici A, Seker M, Kefeli U, Aydin D, Celik S, Demir T, Erkol B. Oven Ustaalioglu BB, et al. Among authors: kefeli u. J Gastrointest Cancer. 2019 Sep;50(3):451-457. doi: 10.1007/s12029-018-0099-y. J Gastrointest Cancer. 2019. PMID: 29637517
Prognostic role of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, and pan-immune-inflammation value in metastatic castration-resistant prostate cancer patients who underwent 177Lu-PSMA-617.
Şahin E, Kefeli U, Zorlu Ş, Seyyar M, Ozkorkmaz Akdag M, Can Sanci P, Karakayali A, Ucuncu Kefeli A, Bakkal Temi Y, Cabuk D, Uygun K. Şahin E, et al. Among authors: kefeli u. Medicine (Baltimore). 2023 Nov 24;102(47):e35843. doi: 10.1097/MD.0000000000035843. Medicine (Baltimore). 2023. PMID: 38013293 Free PMC article.
The real-world outcomes of Lutetium-177 PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer: Turkish Oncology Group multicenter study.
Almuradova E, Seyyar M, Arak H, Tamer F, Kefeli U, Koca S, Sen E, Telli TA, Karatas F, Gokmen I, Turhal NS, Sakalar T, Ayhan M, Ekinci F, Hafizoglu E, Kahraman S, Kesen O, Unal C, Alan O, Celik S, Yekeduz E, Omur O, Gokmen E. Almuradova E, et al. Among authors: kefeli u. Int J Cancer. 2024 Feb 15;154(4):692-700. doi: 10.1002/ijc.34749. Epub 2023 Oct 11. Int J Cancer. 2024. PMID: 37818966
Follicular lymphoma in a patient with splenosis: a case report.
Kefeli U, Mehtap O, Cakir O, Eruyar AT, İsgoren S, Ucuncu Kefeli A. Kefeli U, et al. J Int Med Res. 2020 Mar;48(3):300060519890200. doi: 10.1177/0300060519890200. Epub 2019 Dec 5. J Int Med Res. 2020. PMID: 31802706 Free PMC article.
Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma.
Aydin D, Sendur MA, Kefeli U, Ustaalioglu BB, Aydin O, Yildirim E, Isik D, Ozcelik M, Surmeli H, Oyman A, Isik S, Sener N, Ercelep O, Odabas H, Aliustaoglu M, Gumus M. Aydin D, et al. Among authors: kefeli u. Clin Colorectal Cancer. 2017 Mar;16(1):78-83. doi: 10.1016/j.clcc.2016.04.013. Epub 2016 May 7. Clin Colorectal Cancer. 2017. PMID: 27247089
44 results